Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Bullboard Posts
Comment by toade1313on Mar 26, 2019 8:05am
105 Views
Post# 29535363

RE:For God`s sake

RE:For God`s sakeLOOKING FORWARD TO is not the same as IT WILL START AT THE BEGINNING OF THE 2ND QUARTER!!!!!!  They don't have the REBs yet (or it should have been announced). They have not published any patient 6 data. We shareholders deserve better information. At last year's AGM I specifically asked about the potential for delays in starting phase2 and was assured that this time (As opposed to phase 1) they knew exactly what was required and they were Looking Forward To starting in the 4th quarter 2018 in Canada. Then the projection was moved to 1st quarter 2019. Now it's the beginning of the 2nd quarter 2019. I for one have difficulty believing them. I will not attempt to vote my share at the AGM again. As soon as I get my voting sheets I'm keying in my votes. And as an aside, a week ago on the company site I asked why the increase in total shares from Feb to late March. NO ANSWER. Why have the Ask me feature if they aren't going to respond? 
Bullboard Posts